To evaluate the loss of Keap1 and its effects on Nrf2 overexpression and cellular localization in primary HNSCC tumors, we immunoassayed Nrf2 expression using the anti-Nrf2 antibody in HNSCC primary tumor tissues. Here, KEAP1 is linked to head and neck squamous cell carcinoma.